跳至主要内容
临床试验/EUCTR2007-000532-47-DE
EUCTR2007-000532-47-DE进行中(未招募)不适用

Singleblind, randomized, verum-controlled, multicentric study to confirm the non-inferiority of Leukichtan Gel versus Betaisodona Salbe in the treatment of cuts, abrasions and burns

ICHTHYOL-GESELLSCHAFT Cordes, Hermanni & Co. (GmbH & Co.) KG0 个研究点开始时间: 2009年8月11日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • · age: 7 months - 80 years
  • · male or female Caucasians
  • · voluntary participation in the study
  • · existence of a written consent of the patient, for patients under 18 years of age
  • additionally with signature of a legal representative
  • · diagnosis: superficial, fresh cuts, abrasions or burns, grade I-II, not older than
  • · Safe contraception (female patients) according to Pearl Index < 1 - fulfilled as
  • follows: (one of the following items has to be answered with yes”)
  • - hormonal contraception via estrogens and progestogens for example:
  • oCombined hormonal contraceptive pill (estrogens and progestogens)
  • oMini pill(progestogens only)
  • oContraceptive vaginal ring(ring with estrogens and progestogens)
  • oContraceptive Patch(estrogens and progestogens)
  • oIntrauterine systems (IUS)(with progestogens)
  • - sterilisation
  • - Sexual abstinence (reliable statement) / vasectomised partner
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • · injuries older than 2 days (corresponding to 48 hours)
  • · cuts > 10 cm, abrasions or burns > 100 cm2
  • · severe concomitant diseases (i.e. liver-/kidney disorders, metabolism disorders,
  • tumors in the anamnesis)
  • · hyperthyreosis or other manifest thyroid disease
  • · dermatitis herpetiformis Duhring
  • · patient was or will be treated before or after the study with a radio-iodine-therapy
  • · patient with bland adenomatous goiter
  • · predisposed patient with autonomic adenomas resp. functional autonomy
  • · known hypersensitivity / allergy against iodine or Sodium bituminosulfonate, pale or
  • one of the other ingredients of the investigational product
  • · simultaneous application of enzymatic wound treatment
  • · simultaneous application of hydrogen peroxide and Taurolidin as well as disinfectants
  • containing silver or wound dressings containing silver (formation of silver iodide)
  • · simultaneous or shortly subsequent treatment with disinfectants containing
  • quicksilver (risk of chemical burn due to formation of quicksilver iodide)
  • · existence of diseases that require systemic application of antibiotics or steroids
  • and/or topical administration of antibiotics or steroids in the area of the skin injury
  • · oral and/or topical therapy with corticosteroids
  • · application of other medicinal and/or cosmetical products that can influence the
  • therapy during the study
  • · alcohol, drugs or medicins abuse
  • · physical or psycological diseases where the adherence to the protocol
  • appears to be questionable
  • · lacking compliance
  • · pregnancy, lactation
  • · first-time intake of hormonal contraceptives or change of contraceptives within the
  • last 3 months
  • · participation in another clinical trial within the last 30 days, planned participation
  • in another clinical trial within the duration of this study
  • · previous participation within this study

研究者

相似试验